Descovy 200-25 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F8EV9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,648
Award facts
- Contract value 100% obligated
- $11,648.25 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $11,648.25 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) on January 15, 2026, with completion expected by January 16, 2026. This non-set-aside, competitively awarded contract employs firm fixed-price pricing and will be performed at the vendor's Conshohocken, Pennsylvania location. DESCOVY is an antiretroviral medication used in HIV treatment and prevention, reflecting the Defense Logistics Agency's procurement of critical pharmaceutical supplies for military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031. This prime contract vehicle enables comprehensive global pharmaceutical support across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and vaccines, serving military treatment facilities, the Defense Health Agency, and other federal healthcare institutions. The indefinite delivery vehicle structure allows AmerisourceBergen to efficiently fulfill ongoing federal medical supply requirements without requiring individual competitive solicitations for routine pharmaceutical orders.
Quick answers
Who was awarded contract SPE2DR26F8EV9?
SPE2DR26F8EV9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26F8EV9 worth?
The government has obligated $11,648 on SPE2DR26F8EV9.
Is contract SPE2DR26F8EV9 an order under another contract?
Yes. SPE2DR26F8EV9 is a delivery order under SPE2DR25D3110, an indefinite delivery contract.
Was contract SPE2DR26F8EV9 competed?
The extent of competition for SPE2DR26F8EV9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award